ASH 2010 Conference Coverage

Chemicals in Meat Cooked at High Temperatures and Cancer Risk (Fact Sheet)

This fact sheet examines the possible cancer risks associated with the consumption of heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs) formed in meats cooked via high-temperature methods.

Cancer scan could remove need for radiotherapy in cured patients

PET scan usage for patients with early stage Hodgkin lymphoma could potentially help them avoid unneeded radiotherapy.

BRCA-targeting drug has benefit in prostate cancer

Trials results indicate that the pioneering drug olaparib, which targets inherited mutations, can be beneficial for men with prostate cancer.

New screening technique could identify ovarian cancer in twice as many women

A new screening method utilizing protein analysis can detect ovarian cancer in twice as many women as conventional strategies, according to the latest trial results.

African Americans more likely to exhibit negative perceptions of cancer-related clinical trials

African Americans are more likely to display negative perceptions of participating in cancer-related clinical trials.

Livers donated after cardiac death safe for patients with liver cancer

Patients with liver cancer have the same positive outcomes using organs donated by patients who died as a result of cardiac death.

Metabolic syndrome prevalence is high in the U.S.

Researchers have found a high prevalence of metabolic syndrome in the US population.

Biomarker may affect chemo resistance in patients with advanced ovarian cancer

miR-506 may play a role in chemotherapy resistance in patients with ovarian cancer.

More detailed findings confirm that coffee protects against breast cancer recurrence

For women with breast cancer using the drug tamoxifen, coffee appears to both inhibit tumor growth and reduce recurrence.

A spectrum of cutaneous toxicities from erlotinib may be a robust clinical marker for non-small-cell lung therapy: a case report and literature review

This case study presents a woman with a stage IV lung adenocarcinoma using erlotinib monotherapy, who experienced a spectrum of cutaneous toxicities.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs